Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MercadoLibre | MELI | Sep 20, 2024 | 2 103.75 | -0.27 |
Mercantile Bank | MBWM | Sep 20, 2024 | 44.00 | -5.60 |
Mercer International | MERC | Sep 20, 2024 | 6.30 | -2.17 |
Merchants Bancorp | MBIN | Sep 20, 2024 | 45.57 | -3.37 |
Merchants Bancorp B | MBINO | Sep 20, 2024 | 25.14 | +0.15 |
Merchants Bancorp C Pref | MBINN | Sep 20, 2024 | 22.88 | +0.57 |
Merchants Bancorp Pref D | MBINM | Sep 20, 2024 | 26.53 | -0.71 |
Merck & Co | MRK | Sep 20, 2024 | 117.17 | -0.05 |
Mercurity Fintech | MFH | Sep 20, 2024 | 1.28 | +4.07 |
Mercury General | MCY | Sep 20, 2024 | 60.05 | 0.00 |
Mercury Systems | MRCY | Sep 20, 2024 | 35.90 | +0.96 |
Mereo BioPharma ADR | MREO | Sep 20, 2024 | 4.25 | -0.70 |
Meridian | MRBK | Sep 20, 2024 | 12.46 | 0.00 |
MeridianLink | MLNK | Sep 20, 2024 | 23.91 | -2.01 |
Merit Medical Systems | MMSI | Sep 20, 2024 | 99.56 | -0.67 |
Meritage Homes | MTH | Sep 20, 2024 | 203.33 | -4.85 |
Merrill Lynch & Co. | IPB | Sep 20, 2024 | 26.42 | -1.23 |
Mersana Therapeutics | MRSN | Sep 20, 2024 | 2.16 | -1.37 |
Merus N.V | MRUS | Sep 20, 2024 | 49.67 | -2.24 |
Mesa Air Group | MESA | Sep 20, 2024 | 1.15 | -6.12 |
Mesa Laboratories | MLAB | Sep 20, 2024 | 128.57 | +0.11 |
Mesa Royalty Trust | MTR | Sep 20, 2024 | 5.90 | +0.38 |
Mesabi Royalty Trust | MSB | Sep 20, 2024 | 21.57 | -0.83 |
Mesoblast ADR | MESO | Sep 20, 2024 | 6.85 | +6.86 |
Meta Materials | MMAT | Sep 20, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Sep 20, 2024 | 561.35 | +0.40 |
Metagenomi | MGX | Sep 20, 2024 | 2.45 | -6.84 |
Metal Sky Star Acquisition | MSSA | Sep 20, 2024 | 11.40 | 0.00 |
Metalla Royalty & Streaming | MTA | Sep 20, 2024 | 3.27 | +1.24 |
Metallus | MTUS | Sep 20, 2024 | 15.10 | -4.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.